Gilbert Omenn

Gilbert Omenn

Direktor/Vorstandsmitglied bei GALECTIN THERAPEUTICS INC.

Vermögen: 461 353 $ am 30.09.2026

85 Jahre
Commercial Services
Health Technology
Consumer Services

Profil

Dr. Gilbert S.
Omenn
is an Independent Director at Amesite, Inc., an Independent Director at Galectin Therapeutics, Inc., a Professor at University of Michigan, a Member at American Academy of Arts & Sciences, a Member at Association of American Physicians, a Member at National Academy of Medicine (United States), a Member-Community Preventive Services Task Force of Centers for Disease Control & Prevention and a Vice President at Human Proteome Organization.
He is on the Board of Directors at Amesite, Inc., Galectin Therapeutics, Inc., Armune BioScience, Inc., Life Sciences Society, MedsynBio LLCuu, Oncofusion Therapeutics, Inc., Phenomics Health, Inc., Population Services International, Salzburg Global Seminar, Inc., The Center for Public Integrity, The Hastings Center and The CNA Corp.
Dr. Omenn was previously employed as an Independent Director by Angion Biomedica Corp., a Council Member by National Academy of Medicine (United States), an Independent Director by Esperion Therapeutics, Inc., a Member-Scientific Management Review by National Institutes of Health, a Chief Executive Officer by University of Michigan Health System, a Chief Executive Officer by University of Miami Health System, an Independent Director by Amgen, Inc., a Professor by University of Washington, an Associate Director by Office of Management & Budget, an Associate Director by Office of Science & Technology Policy, a President by American Association for the Advancement of Science, a Member by American College of Physicians, Inc. /Old/, an Advisor by Arboretum Ventures LLC, a Member by Fred Hutchinson Cancer Research Center, an Affiliate Faculty by Institute for Systems Biology, and a Chairman by tranSMART Foundation.
He also served on the board at Amesite, Inc. /Old/, Etubics Corp., Trukera Medical, Rohm & Haas Co., Fred Hutchinson Cancer Research Center, Unitunited Way Foundation and US Civilian Research & Development Foundation.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
28.02.2026 82 240 ( 0,08 % ) 319 091 $ 30.09.2026
30.09.2026 143 699 ( 2,19 % ) 142 262 $ 30.09.2026

Aktive Positionen von Gilbert Omenn

UnternehmenPositionBeginn
GALECTIN THERAPEUTICS INC. Direktor/Vorstandsmitglied 23.09.2014
AMESITE INC. Direktor/Vorstandsmitglied 01.03.2020
Direktor/Vorstandsmitglied -
Corporate Officer/Principal -
Direktor/Vorstandsmitglied -
MedsynBio LLCuu
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied 20.05.2011
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied 18.04.2011
░░░░░░░░ ░░░░░░░ ░░ ░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -

Ehemalige bekannte Positionen von Gilbert Omenn

UnternehmenPositionEnde
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░ ░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Gilbert Omenn im Detail an

Ausbildung von Gilbert Omenn

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

90

Beziehungen ersten Grades

41

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen41

Health Technology

Process Industries

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Consumer Services

Consumer Services

Consumer Services

Government

Government

Commercial Services

Consumer Services

Commercial Services

Government

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Human Proteome Organization

Commercial Services

Health Technology

Commercial Services

Commercial Services

Consumer Services

Commercial Services

Miscellaneous

Commercial Services

Life Sciences Society

Health Services

Health Technology

Commercial Services

Finance

Technology Services

Technology Services

Office of Management & Budget

MedsynBio LLCuu

Finance

  1. Börse
  2. Insiders
  3. Gilbert Omenn